Portugal – Reagents and contrast media – Fornecimento de reagentes e tecnologia para a UIPM e LHO

Portugal – Pharmaceutical products – CI/1008/2026 Aquisição de Gases Medicinais, para a ULSTMAD, EPE.

Portugal – Medical equipments – 12025426 - FORNECIMENTO DE LENTES INTRAOCULARES E OUTRO MATERIAL DE OFTALMOLOGIA, DESTINADAS À UNIDADE LOCAL DE SAÚDE DE SÃO JOSÉ, EPE, PARA 2026

Portugal – Pharmaceutical products – 2023/0491 - VEDOLIZUMAB [300 MG PÓ CONC SOL INJ FRS]

Expected Outcome: the proposals under this call are expected to address one or more of the following subjects : • Enhanced personalized monitoring, care and treatments, focusing on the development of highly customized healthcare solutions, including the required research and diagnostic tools, tailored to individual needs, covering various scenarios such as chronic disease management, physiotherapy, precision diagnosis, personalized medicine/treatment, pre- and postoperative care, and daily assistance in homes and common spaces. It also targets effective management of chronic diseases and elderly care through personalized monitoring and interventions facilitated by advanced sensor technologies and edge-to-cloud solutions. This includes the development and integration of solutions for Hospitalization at Home, enabling patients to receive complex, remotely supervised care using intelligent medical devices capable of sensing, analysing, and transmitting real-time data. This requires a continuum, from in-hospital diagnostics to robust, long-term patient support at home via AI-driven care pathways and hospitalization at home. • Prevention and treatment of diseases, allowing the improved…

Expected Outcome: Proposals submitted to this call are expected to address several of the following elements: • Scaling of wafer-level photonic processes for key materials (e.g. SiN, InP, GaAs),including process integration, yield optimisation, and manufacturability at highvolumes. • Development of packaging and test solutions that are scalable, automated, andcompatible with co-packaged optics and advanced photonic-electronic integration. • Integration of heterogeneous materials and components, such as on-chip lasers,modulators, and detectors, using advanced packaging and assembly approaches. • Design-process-equipment co-optimisation, enabling repeatable, cost-effectiveproduction of complex photonic circuits and systems, including use of PDKs andvalidated building blocks. • Demonstration of system-level functionality through application-relevant use casesin strategic sectors (e.g. AI, sensing, telecommunication, mobility, health, defence),with quantified performance metrics and clear market relevance.

Provision of Non-Emergency Patient Transport Services (NEPTS) for GHFT. Additional information: GHFT (Gloucestershire Hospitals NHS Foundation Trust) "the Authority" invites Bidders to compete for the Provision of Non-Emergency Patient Transport Services (NEPTS) for GHFT. This procurement is being undertaken Provider Selection Regime which came into force on 1 January 2024. This Tender is only open all suppliers The Tender information can be found on the Trusts e-Portal (Atamis Health Family) at https://health-family.force.com/s/Welcome. Reference - C457853 You must be registered on the Atamis to view the Documents and all bids and communications must be submitted via this e-Portal. If you require any technical assistance using Atamis, please refer to the Supplier Portal user guide ( https://services.atamis.co.uk/docs/Supplier_User_Guide.pdf ) and/or the helpdesk on 0800 0988 201.

Scope: Proposals innovations should address one or more of the several domains : WBG substrates to reduce EU dependency on material and provide more sustainable, industrially compatible solutions. WBG platform for cost effectiveness, available in 300mm for GaN and/or SiC to improve yield and power density and close gaps in the value chain. A toolbox (e.g. wafer cut, smart stacking, thin layer transfer, epitaxy, UWBG materials) for further innovation schemes. Next generation or optimised new power semiconductor devices fitting their application. Adding intelligence to power semiconductor devices on control and/or sensor side. Facilitate the propagation of EU Packaging/Integration excellence along the entire value chain e.g. pre-packages or power semiconductor device packaging solutions to enable power device/system integration and strengthen Europe’s competitiveness in advanced packaging. Explore the use of heterogeneous and functional integration for improved performance, reliability, robustness and cost competitiveness. Rising operative voltage, frequency, current and thermal features that are common challenge on power electronics across the different application sectors. Provide…

Expected Outcome: The proposals under this topic should address the design/specification and implementation/testing of the key microelectronics building blocks of an FR3 FEM paving the way towards their future integration into a complete integrated FEM system. • Progresses the State of the art to optimise the cost-performance trade off to serve the target ITU IMT 2030 specifications, notably for what concerns maximum data rate, user data rate, spectral efficiency, whilst enabling 50% mobile transmission system energy consumption; • Allows operational implementation of spectrum sharing with other spectrum users within the selected FR3 sub-band; • Enables large arrays integration for increased path loss compensation at FR3 frequencies with very compact, low power, high efficiency FEM integration; • Enables high bandwidth for carrier aggregation with broadband RF transceivers; • Enables SBFD (Sub-Band non overlapping Full-Duplex) for UL coverage extension (Rel.-19 5G-Advanced in 3GPP) with appropriate interference cancellation techniques; • Enables ISAC (Integrated Sensing and Communications) supporting monostatic as well as bistatic radar functionality, and addressing interference…

UK registered organisations can apply for a share of up to £121 million across the three strands of this competition for innovative clean maritime technologies. This funding is from the Department for Transport (DfT).

Poland – Pharmaceutical products – Dostawa produktów leczniczych wykorzystywanych przez oddziały szpitala, leki stosowane w ramach programów lekowych oraz chemioterapii (część 1)